[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $jcrrf JCR Pharmaceuticals ($jcrrf) enters a strategic collaboration for Alzheimer's treatment. The partnership combines technologies for enhanced brain drug delivery, sparking positive engagement. ### About $jcrrf JCR Pharmaceuticals ($jcrrf) is a pharmaceutical company. ### Engagements: XX [#](/topic/$jcrrf/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$jcrrf/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XX **1-Year High**: XXX on 2025-07-15 **1-Year Low**: XX on 2025-07-16 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$jcrrf/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$jcrrf/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1-Year High**: X on 2025-06-28 **1-Year Low**: X on 2025-06-28 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$jcrrf/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$jcrrf/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $jcrrf in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1-Year High**: X on 2025-06-28 **1-Year Low**: X on 2025-06-28 **Top topics mentioned** In the posts about $jcrrf in the last XX hours [$4552t](/topic/$4552t), [$abos](/topic/$abos) ### Top Social Posts [#](/topic/$jcrrf/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$ABOS - Acumen Pharmaceuticals & $JCRRF JCR Pharmaceuticals 🔹Enter Strategic Collaboration Option and License Agreement 🔹To Develop Enhanced Brain Delivery Therapy for Alzheimer's Disease 🔹Strategic partnership combines complementary technologies to enhance brain drug delivery 🔹Sabirnetug showed positive Phase X results with low ARIA-E rates and significant amyloid plaque reduction 🔹Large Phase X trial already fully enrolled with XXX patients 👇 XXX% PreM/ $1.40" [@JohnZidar](/creator/x/JohnZidar) on [X](/post/tweet/1945086422525878391) 2025-07-15 11:41:55 UTC 5854 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
JCR Pharmaceuticals ($jcrrf) enters a strategic collaboration for Alzheimer's treatment. The partnership combines technologies for enhanced brain drug delivery, sparking positive engagement.
JCR Pharmaceuticals ($jcrrf) is a pharmaceutical company.
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XXX on 2025-07-15
1-Year Low: XX on 2025-07-16
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-06-28
1-Year Low: X on 2025-06-28
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $jcrrf in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1-Year High: X on 2025-06-28
1-Year Low: X on 2025-06-28
Top topics mentioned In the posts about $jcrrf in the last XX hours
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ABOS - Acumen Pharmaceuticals & $JCRRF JCR Pharmaceuticals 🔹Enter Strategic Collaboration Option and License Agreement 🔹To Develop Enhanced Brain Delivery Therapy for Alzheimer's Disease 🔹Strategic partnership combines complementary technologies to enhance brain drug delivery 🔹Sabirnetug showed positive Phase X results with low ARIA-E rates and significant amyloid plaque reduction 🔹Large Phase X trial already fully enrolled with XXX patients 👇 XXX% PreM/ $1.40"
@JohnZidar on X 2025-07-15 11:41:55 UTC 5854 followers, XXX engagements
/topic/$jcrrf